Management of Male Breast Cancer: ASCO Guideline

The guideline recommends that many of the management approaches used for men with breast cancer are like those used for women. Men with hormone receptor–positive breast cancer who are candidates for adjuvant endocrine therapy should be offered tamoxifen for 5yrs initially.


Journal of Clinical Oncology